Publications

District Court Invalidates Part of the Procedure for Assessing the ACA’s Employer Mandate Penalty

In a decision with far-reaching implications, the U.S. District Court for the Northern District of Texas, issued a decision in Faulk Company, Inc. v. Xavier Becerra et al., invalidating an assessment against Faulk Company for failure to provide its employees with health coverage.​ This assessment, called an Employer Shared Responsibility Payment (“ESRP”), is an excise tax that is assessed against employers of a certain size who fail to offer their full-time employees health coverage that meets applicable requirements of the Affordable Care Act (“ACA”). More importantly, the Court also invalidated the regulations by which the Internal Revenue Service (“IRS”) assesses the ESRP. If not overturned by an appellate court, this decision could arguably result in the invalidation of all ESRPs previously assessed by the IRS. The Court’s decision relies on an interpretation of the interaction between two provisions of the ACA, each under the jurisdiction of a different agency: (i) Section

Read More »

ERISA and Prescription Drug Costs: The Latest on Fiduciary Breach Class-Action Lawsuits

Lawsuits over what ERISA group health plans pay for prescription drugs continue full speed ahead, with plaintiffs in Lewandowski v. Johnson & Johnson filing an amended complaint to try to shore up standing, a dismissal in the lawsuit against Wells Fargo, and a new case filed against JPMorgan landing in court just this month. For prior Trucker Huss alerts on the original Lewandowski complaint and the court’s dismissal, see https://www.truckerhuss.com/2024/03/the-cost-of-drugs-johnson-johnson-lawsuit-could-signal-the-opening-of-a-new-area-of-erisa-class-action-litigation-against-health-plan-fiduciaries and https://www.truckerhuss.com/2025/01/lewandowski-v-johnson-johnson-unable-in-first-try-to-pursue-fiduciary-breach-claims-for-high-costs-of-drugs. Lewandowski v. Johnson & Johnson In early 2024, plaintiff Ann Lewandowski filed a class action lawsuit against Johnson & Johnson (J&J) and the fiduciaries of J&J’s prescription drug benefits program (the “J&J Defendants”) in the District of New Jersey (the “Court”). Lewandowski’s claims were premised on an alleged violation of ERISA’s fiduciary duty of prudence. At a high level, Lewandowski claimed that the J&J Defendants acted imprudently by failing to manage the drug costs of two J&J-sponsored health plans. The initial complaint contained many allegations,

Read More »

Supreme Court Puts To Rest the Pleading Standard in ERISA Prohibited Transaction Cases And Opens The Door To More Litigation

Over the past two decades, a lot of (very expensive) ink has been spilled in courts around the country in ERISA litigation cases regarding a single question: how much does a plaintiff need to say in a complaint alleging that a prohibited transaction has occurred, to survive an early motion to dismiss? The question seems very academic, at first, but the answer has significant implications for sponsors and fiduciaries of employee benefit plans. On April 17, 2025, a unanimous Supreme Court weighed in, resolved a split between federal circuit courts and put the issue to rest, concluding that plaintiffs alleging violations of ERISA’s prohibited transaction provisions need not plead facts to show that service provider arrangements are unreasonable, but rather that it is the burden of defendants to plead and prove that arrangements between plans and service providers are reasonable and no more than reasonable compensation is paid for those

Read More »

HHS Best Practices for ePHI Protection: What We Can Learn from the Proposed Modifications to the HIPAA Security Rule—Regardless of Whether It Becomes Final

In an effort to strengthen cybersecurity protections for electronic protected health information (ePHI), at the end of last year the Department of Health and Human Services (HHS) ₋₋ through its Office of Civil Rights (OCR) ₋₋ issued a Notice of Proposed Rulemaking (NPRM) to modify the Security Standards for the Protection of Electronic Protected Health Information (“Security Rule”) under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH Act). The NPRM has received over 4,000 comments from HIPAA-regulated entities, healthcare industry stakeholders and the public. As discussed in this article, while it is unclear whether this proposed rule will be finalized (and if so, in what form), the NPRM contains helpful guidance for plan sponsors on what OCR considers to be best practices as it relates to the protection of ePHI. Background The HIPAA Security

Read More »

Court Finds American Airlines Liable for Breach of Fiduciary Duty of Loyalty to its 401(k) Plans Because it Allowed BlackRock to Pursue ESG Objectives in its Proxy Voting

In Spence v. American Airlines, Inc., after a four-day bench trial in the Northern District of Texas, U.S. District Court Judge O’Connor ruled that American Airlines breached its fiduciary duty of loyalty under the Employee Retirement Income Security Act of 1974 (“ERISA”) by allowing BlackRock Institutional Trust Company, Inc. (“Blackrock”), as manager of all its passively managed non-ESG investments in American Airlines 401(k) plans, to use proxy voting policies to further environmental, social, and governance (“ESG”) objectives. (Spence v. Am. Airlines, Inc., No. 4:23-CV-00552-O, (Dkt. 157) (N.D. Tex. Jan. 10, 2025) (Findings of Fact and Conclusions of Law) (“Am. Airlines II”).)  This case differs from the typical 401(k) plan “excessive fee” case where participants argue that an ERISA plan paid too much for investment management.  On the contrary, here the district court acknowledged that American Airline’s plans paid low rates for investment management fees, and focused instead on the relationship

Read More »

EBSA Adds Self-Correction Component to Voluntary Fiduciary Correction Program Update

On January 15, 2025, the Employee Benefits Security Administration (EBSA) published a final rule updating its Voluntary Fiduciary Correction (VFC) Program (the “Updated VFC Program”), based on proposed rules issued in November of 2022. The Updated VFC Program will take effect on March 17, 2025. The most significant changes to the VFC under the Updated VFC Program are the addition of two new self-correction features for common plan failures: Other changes under the revised program include (i) alternative corrections for prohibited transactions involving certain plan loans made at below-market interest rates, (ii) corrections for purchase and sale transactions involving the plan and parties in interest, and certain clarifying changes. This article focuses on the new self-correction opportunities. VFC Application Process.  Under the prior version of VFC (effective through March 16, 2025), plan fiduciaries were permitted to correct certain fiduciary breach violations and prohibited transactions under the Employee Retirement Income Security

Read More »
  • Search

  • Recent Posts

  • Archives

  • Practice Areas

  • Office Locations

    SAN FRANCISCO


    135 Main Street, 9th Floor

    San Francisco, CA 94105-1815

    LOS ANGELES


    15760 Ventura Boulevard, Suite 910

    Los Angeles, CA 91436-2964

    PORTLAND

    329 NE Couch Street, Suite 200

    Portland, OR 97232-1332

    Awards & Recognition